Smithkline Beckman Corp, part of GSK Plc, is an American company located in Philadelphia, PA, involved in pharmaceutical preparations. On July 27, 1989 Smithkline Beecham Plc acquired Smithkline Beckman Corp for $16,082.37 million.

Established in 1987, Korea United Pharm. Inc. has continued to develop as a pharmaceutical company with its slogan of "Korean owned multinational pharmaceutical company." We have continuously launched new pharmaceutical drugs such as Cilostan CR Tab, Gastiin CR Tab, Clanza CR Tab and etc., through prestigious R&D investment, abundant know-hows and top expert researchers and have been placed as a strong competitor in the pharmaceutical drug development industry. they were named one of Asia's 200 most promising companies by the US economy magazine Forbes.

Auspherix Ltd. operates as an early stage anti-infectives company which develops novel antibiotics to treat resistant bacterial diseases. The firm uses a library screening approach to identify drugs with novel mechanisms of action as antibiotics. The company was founded by Ian Charles and Dagmar Alber in 2013 and is headquartered in Stevenage, the United Kingdom.

Korea Research Institute of Bioscience and Biotechnology (KRIBB) is a government research institute in Daejeon, South Korea. It is dedicated to biotechnology research across a broad span of expertise, from basic studies for the fundamental understanding of life phenomena to applied studies such as drug discovery, novel biomaterials, integrated biotechnology and bioinformation.

Connetics Corp. develops and commercializes dermatology products. The firm offers remedies for psoriasis in adults, eczema, seborrheic dermatitis, and acne. The company was founded in 1993 and is headquartered in Palo Alto, CA.

Kunming Institute of Precious Metals is a Chinese private company located in Kunming. The firm engages in scientific research institute that specializing in the development of precious metals.

SBI Pharmaceuticals is a treatment foundation, and treatment methods vary greatly depending on whether or not the cancer has invaded the muscle layer. Non-muscle invasive bladder cancer accounts for approximately half of all cases. Bladder tumour resection (also known as bladder cancer endoscopic resection, TURBT) removes the cancer while leaving the bladder intact.

Wholesales machines and equipment

Mitsui Chemicals, Inc. manufactures and sells petrochemicals and industrial inorganic chemical products. It operates through the following segments: Mobility, Healthcare, Food and Packaging, Base Material, and Others. The Mobility segment covers the new product development support business (solution business) for elastomers, functional compounds, functional polymers, polypropylene compounds, automobiles and other industrial products. The Healthcare segment includes vision care material, non-woven fabric, dental material, and personal care material. The Food and Packaging segment handles the coating and functional materials, functional films and sheets, and agricultural chemicals. The Base Material segment covers the ethylene, propylene, polyethylene, polypropylene, catalysts, phenols, high-purity terephthalic acid, PET resins, polyurethane materials, and industrial chemicals. The Others segment comprises of other related businesses. The company was founded on July 1, 1955 and is headquartered in Tokyo, Japan.

The Board of Regents of The University of Texas System, a subsidiary of The University of Texas at Austin, is an American company located in Austin, TX. The firm oversees college activities.

The National Institute of Advanced Industrial Science and Technology (AIST), led by President Chubachi, is a public research institution funded by the Japanese government to a large extent. The present AIST is a rather new research organization established in 2001. However, AIST and its predecessor organizations have been contributing to society through continuous advancement in technologies and support to Japanese industries since 1882. Headquarters of AIST are located in Tsukuba and Tokyo. AIST has over 40 autonomous research units in various innovative research fields, and the units are located at ten research bases and several sites (smaller than research bases) of AIST all over Japan. About 2300 researchers (about 2000 with tenure: about 80 from abroad) and a few thousands of visiting scientists, post-doctoral fellows, and students from home and abroad are working at AIST. About 650 permanent administrative personnel and many temporary staff support research works of AIST.

Guangdong Anke Technology Co., Ltd., established on 2012-12-27, Business scope includes research and development of film machinery technology,technology transfer;research and development,Production,Sales:glass film,film,Explosion-proof film,solar film,optical film,car film,Home Furniture Film,High Performance Membrane Materials,nanomaterials,composite material,Optoelectronic materials,Polymer Materials,Hardware,Equipment,plastic products;Production,Sales:High-purity elements and compounds,Surface Functional Materials,New Organic Active Materials,new membrane material,Functional glass and new optical materials,Eco-environmental material,high quality synthetic rubber,high performance sealing material,Super material,Graphene material,3DPrint base material,superconducting material,Engineering plastics and synthetic resins,High Performance Fibers and Composite Materials,Metal matrix composites and ceramic matrix composites,Soft Magnetic Composite,Green Composite Materials for Rail Transit;Sales:Office Supplies,electronic product,Communication equipment and supporting equipment,automobile parts,Synthetic resin,plastic products,rubber products,building materials,decorative material,jewelry,Stationery,pet supplies,baby products,decorative items,Kitchenware and daily necessities,smart wearable device;Internet Merchandise Sales(Except for licensed and approved products);Import and export of goods or technology(Except for the import and export of goods and technologies that are prohibited by the state or involve administrative approval);New material technology promotion service;Natural science research and experimental development.(The above business scope does not contain hazardous chemicals)(The above business scope involves the import and export of goods,Technology Import and Export)(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments.)(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA.

Yangshengtang Co., Ltd. engages in the management of pharmaceutical and food products. Its business activities include road cargo transportation, catering services, product packaging design, real estate development, housing rental services, business management consulting, and marketing planning services. It sells cosmetics, clothing, furniture, paper, office equipment, electronic products, communication equipment, agricultural and fishery products, and chemical products. The company was founded on March 12, 1993 and is headquartered in Hangzhou, China.

Manufactures typewriters, paints, paper products and chemicals

The Istituto Superiore di Sanità (Italian National Institute of Health), also ISS, is an Italian public institution that, as the leading technical-scientific body of the Italian National Health Service (Servizio Sanitario Nazionale), performs research, trials, control, counseling, documentation and training for public health. The Institute is under the supervision of the Ministero della Salute (Ministry of Health).

Callisto Pharmaceuticals, Inc. is a development stage biopharmaceutical company. The company operates through two subsidiary companies: Pharmaceuticals, Inc and Callisto Research Labs, LLC. It focuses primarily on the development of drugs to treat gastrointestinal disorder and diseases and rheumatoid arthritis and develops novel therapeutics to treat cancer. The company was founded by Judson A. Cooper and Joshua D. Schein in 1996 and is headquartered in New York, NY.